Skip to main content
Top
Published in: HAND 1/2014

01-03-2014 | Review

Dupuytren's disease: current state of the art

Author: Mark Henry

Published in: HAND | Issue 1/2014

Login to get access

Abstract

Background

This review article critically examines the current literature for Dupuytren's disease.

Methods

Five procedures are considered: dermofasciectomy, limited fasciectomy, segmental aponeurectomy, needle aponeurotomy, and collagenase injection. Studies regarding the efficacy of these treatments focus primarily on the initial degree of correction, rate of recurrence, and complications.

Results

No one treatment has been declared superior and substantial controversy exists. Comparison between studies has been hampered by the absence of uniform definitions for clinical success and measurable disease progression. Traditional post-operative care includes formal therapy and night splinting, but recent studies have questioned the value of these adjuncts.

Conclusion

The extent of involvement at which the surgeon should intervene was previously well accepted by convention, but as the paradigm shifts towards less invasive procedures, treatment may be offered at an earlier stage. Future research should be structured to recognize the value-based decision making used by patients when selecting treatment.
Literature
1.
go back to reference Abe Y, Rokkaku T, Ofuchi W, et al. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg (Br). 2004;29(5):427–30.CrossRef Abe Y, Rokkaku T, Ofuchi W, et al. An objective method to evaluate the risk of recurrence and extension of Dupuytren's disease. J Hand Surg (Br). 2004;29(5):427–30.CrossRef
2.
go back to reference Armstrong JR, Hurren JS, Logan AM. Dermofasciectomy in the management of Dupuytren's disease. J Bone Joint Surg Br. 2000;82(1):90–4.PubMedCrossRef Armstrong JR, Hurren JS, Logan AM. Dermofasciectomy in the management of Dupuytren's disease. J Bone Joint Surg Br. 2000;82(1):90–4.PubMedCrossRef
3.
go back to reference Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg [Am]. 2000;25(4):629–36.CrossRef Badalamente MA, Hurst LC. Enzyme injection as nonsurgical treatment of Dupuytren's disease. J Hand Surg [Am]. 2000;25(4):629–36.CrossRef
4.
go back to reference Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg [Am]. 2007;32(6):767–74.CrossRef Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg [Am]. 2007;32(6):767–74.CrossRef
5.
go back to reference Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg [Am]. 2002;27(5):788–98.CrossRef Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg [Am]. 2002;27(5):788–98.CrossRef
6.
go back to reference Bainbridge C, Gerber RA, Szczypa PP, et al. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture. J Plast Surg Hand Surg. 2012;46(3–4):177–83.PubMedCentralPubMedCrossRef Bainbridge C, Gerber RA, Szczypa PP, et al. Efficacy of collagenase in patients who did and did not have previous hand surgery for Dupuytren's contracture. J Plast Surg Hand Surg. 2012;46(3–4):177–83.PubMedCentralPubMedCrossRef
7.
go back to reference Balaguer T, David S, Ihrai T, et al. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eu. 2009;34(4):493–6.CrossRef Balaguer T, David S, Ihrai T, et al. Histological staging and Dupuytren's disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eu. 2009;34(4):493–6.CrossRef
8.
go back to reference Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren's disease—a systematic review. J Hand Surg Eu. 2010;35(8):623–6.CrossRef Becker GW, Davis TR. The outcome of surgical treatments for primary Dupuytren's disease—a systematic review. J Hand Surg Eu. 2010;35(8):623–6.CrossRef
9.
go back to reference Beyermann K, Prommersberger KJ, Jacobs C, et al. Severe contracture of the proximal interphalangeal joint in Dupuytren's disease: does capsuloligamentous release improve outcome? J Hand Surg (Br). 2004;29(3):240–3.CrossRef Beyermann K, Prommersberger KJ, Jacobs C, et al. Severe contracture of the proximal interphalangeal joint in Dupuytren's disease: does capsuloligamentous release improve outcome? J Hand Surg (Br). 2004;29(3):240–3.CrossRef
10.
go back to reference Budd HR, Larson D, Chojnowski A, et al. The QuickDASH score: a patient-reported outcome measure for Dupuytren's surgery. J Hand Ther. 2011;24(1):15–20.PubMedCrossRef Budd HR, Larson D, Chojnowski A, et al. The QuickDASH score: a patient-reported outcome measure for Dupuytren's surgery. J Hand Ther. 2011;24(1):15–20.PubMedCrossRef
11.
go back to reference Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg [Am]. 2005;30(5):1021–5.CrossRef Bulstrode NW, Jemec B, Smith PJ. The complications of Dupuytren's contracture surgery. J Hand Surg [Am]. 2005;30(5):1021–5.CrossRef
12.
go back to reference Chen NC, Shauver MJ, Chung KC. Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture. J Hand Surg [Am]. 2011;36(11):1826–34.CrossRef Chen NC, Shauver MJ, Chung KC. Cost-effectiveness of open partial fasciectomy, needle aponeurotomy, and collagenase injection for Dupuytren contracture. J Hand Surg [Am]. 2011;36(11):1826–34.CrossRef
13.
go back to reference Chen NC, Srinivasan RC, Shauver MJ, et al. A systematic review of outcomes of fasciotomy, aponeurectomy, and collagenase treatments for Dupuytren's contracture. HAND. 2011;6(3):250–5.PubMedCrossRef Chen NC, Srinivasan RC, Shauver MJ, et al. A systematic review of outcomes of fasciotomy, aponeurectomy, and collagenase treatments for Dupuytren's contracture. HAND. 2011;6(3):250–5.PubMedCrossRef
14.
go back to reference Citron N, Hearnden A. Skin tension in the aetiology of Dupuytren's disease; a prospective trial. J Hand Surg (Br). 2003;28(6):528–30.CrossRef Citron N, Hearnden A. Skin tension in the aetiology of Dupuytren's disease; a prospective trial. J Hand Surg (Br). 2003;28(6):528–30.CrossRef
15.
go back to reference Citron ND, Nunez V. Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions. J Hand Surg (Br). 2005;30(6):563–6.CrossRef Citron ND, Nunez V. Recurrence after surgery for Dupuytren's disease: a randomized trial of two skin incisions. J Hand Surg (Br). 2005;30(6):563–6.CrossRef
16.
go back to reference Clibbon JJ, Logan AM. Palmar segmental aponeurectomy for Dupuytren's disease with metacarpophalangeal flexion contracture. J Hand Surg (Br). 2001;26(4):360–1.CrossRef Clibbon JJ, Logan AM. Palmar segmental aponeurectomy for Dupuytren's disease with metacarpophalangeal flexion contracture. J Hand Surg (Br). 2001;26(4):360–1.CrossRef
17.
go back to reference Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57(1):13–7.PubMedCrossRef Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57(1):13–7.PubMedCrossRef
18.
go back to reference Crean SM, Gerber RA, Le Graverand MP, et al. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies. J Hand Surg Eu. 2011;36(5):396–407.CrossRef Crean SM, Gerber RA, Le Graverand MP, et al. The efficacy and safety of fasciectomy and fasciotomy for Dupuytren's contracture in European patients: a structured review of published studies. J Hand Surg Eu. 2011;36(5):396–407.CrossRef
19.
go back to reference Denkler K. Surgical complications associated with fasciectomy for Dupuytren's disease: a 20-year review of the English literature. Eplasty. 2010;10:116–33. Denkler K. Surgical complications associated with fasciectomy for Dupuytren's disease: a 20-year review of the English literature. Eplasty. 2010;10:116–33.
20.
go back to reference Desai SS, Hentz VR. The treatment of Dupuytren's disease. J Hand Surg [Am]. 2011;36(5):936–42.CrossRef Desai SS, Hentz VR. The treatment of Dupuytren's disease. J Hand Surg [Am]. 2011;36(5):936–42.CrossRef
21.
go back to reference Di Benedetti DB, Nguyen D, Zografos L, et al. Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study. HAND. 2011;6:149–58.CrossRef Di Benedetti DB, Nguyen D, Zografos L, et al. Prevalence, incidence, and treatments of Dupuytren's disease in the United States: results from a population-based study. HAND. 2011;6:149–58.CrossRef
22.
go back to reference Dias JJ, Braybrooke J. Dupuytren's contracture: an audit of the outcomes of surgery. J Hand Surg (Br). 2006;31(5):514–21.CrossRef Dias JJ, Braybrooke J. Dupuytren's contracture: an audit of the outcomes of surgery. J Hand Surg (Br). 2006;31(5):514–21.CrossRef
23.
go back to reference Donaldson OW, Pearson D, Reynolds R, et al. The association between intraoperative correction of Dupuytren's disease and residual postoperative contracture. J Hand Surg Eu. 2010;35(3):220–3.CrossRef Donaldson OW, Pearson D, Reynolds R, et al. The association between intraoperative correction of Dupuytren's disease and residual postoperative contracture. J Hand Surg Eu. 2010;35(3):220–3.CrossRef
24.
go back to reference Eaton C. Percutaneous fasciotomy for Dupuytren's contracture. J Hand Surg [Am]. 2011;36:910–5.CrossRef Eaton C. Percutaneous fasciotomy for Dupuytren's contracture. J Hand Surg [Am]. 2011;36:910–5.CrossRef
25.
go back to reference Ebskov LB, Boeckstyns ME, Sorensen AI, et al. Results after surgery for severe Dupuytren's contracture: does a dynamic extension splint influence outcome? Scand J Plast Reconstr Surg Hand Surg. 2000;34(2):155–60.PubMedCrossRef Ebskov LB, Boeckstyns ME, Sorensen AI, et al. Results after surgery for severe Dupuytren's contracture: does a dynamic extension splint influence outcome? Scand J Plast Reconstr Surg Hand Surg. 2000;34(2):155–60.PubMedCrossRef
26.
go back to reference Evans RB, Dell PC, Fiolkowski P. A clinical report of the effect of mechanical stress on functional results after fasciectomy for Dupuytren's contracture. J Hand Ther. 2002;15(4):331–9.PubMedCrossRef Evans RB, Dell PC, Fiolkowski P. A clinical report of the effect of mechanical stress on functional results after fasciectomy for Dupuytren's contracture. J Hand Ther. 2002;15(4):331–9.PubMedCrossRef
27.
go back to reference Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg (Br). 2003;28:427–31.CrossRef Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg (Br). 2003;28:427–31.CrossRef
28.
go back to reference Gilpin D, Coleman S, Hall S, et al. Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease. J Hand Surg [Am]. 2010;35(12):2027–38.CrossRef Gilpin D, Coleman S, Hall S, et al. Injectable collagenase clostridium histolyticum: a new nonsurgical treatment for Dupuytren's disease. J Hand Surg [Am]. 2010;35(12):2027–38.CrossRef
29.
go back to reference Hall PN, Fitzgerald A, Sterne GD, et al. Skin replacement in Dupuytren's disease. J Hand Surg (Br). 1997;22(2):193–7.CrossRef Hall PN, Fitzgerald A, Sterne GD, et al. Skin replacement in Dupuytren's disease. J Hand Surg (Br). 1997;22(2):193–7.CrossRef
30.
go back to reference Hindocha S, Stanley JK, Watson S, et al. Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg [Am]. 2006;31(10):1626–34.CrossRef Hindocha S, Stanley JK, Watson S, et al. Dupuytren's diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg [Am]. 2006;31(10):1626–34.CrossRef
31.
go back to reference Hovius SE, Kan HJ, Smit X, et al. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast Reconstr Surg. 2011;128(1):221–8.PubMedCrossRef Hovius SE, Kan HJ, Smit X, et al. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast Reconstr Surg. 2011;128(1):221–8.PubMedCrossRef
32.
go back to reference Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361:968–79.PubMedCrossRef Hurst LC, Badalamente MA, Hentz VR, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med. 2009;361:968–79.PubMedCrossRef
33.
go back to reference Jerosch-Herold C, Shepstone L, Chojnowski AJ, et al. Severity of contracture and self-reported disability in patients with Dupuytren's contracture referred for surgery. J Hand Ther. 2011;24(1):6–10.PubMedCrossRef Jerosch-Herold C, Shepstone L, Chojnowski AJ, et al. Severity of contracture and self-reported disability in patients with Dupuytren's contracture referred for surgery. J Hand Ther. 2011;24(1):6–10.PubMedCrossRef
34.
go back to reference Jerosch-Herold C, Shepstone L, Chojnowski AJ, et al. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskeletal Disord. 2011;12:136.CrossRef Jerosch-Herold C, Shepstone L, Chojnowski AJ, et al. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren's contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskeletal Disord. 2011;12:136.CrossRef
35.
go back to reference McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized controlled study. J Hand Surg [Am]. 2012;37(7):1307–12.CrossRef McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized controlled study. J Hand Surg [Am]. 2012;37(7):1307–12.CrossRef
36.
go back to reference Misra A, Jain A, Ghazanfar R, et al. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease. J Hand Surg [Am]. 2007;32(2):240–5.CrossRef Misra A, Jain A, Ghazanfar R, et al. Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease. J Hand Surg [Am]. 2007;32(2):240–5.CrossRef
37.
go back to reference Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren's disease. J Hand Surg (Br). 1996;21(6):797–800.CrossRef Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren's disease. J Hand Surg (Br). 1996;21(6):797–800.CrossRef
38.
go back to reference Peimer CA, Blazar P, Coleman S, et al. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg [Am]. 2013;38(1):12–22.CrossRef Peimer CA, Blazar P, Coleman S, et al. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg [Am]. 2013;38(1):12–22.CrossRef
39.
go back to reference Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. J Hand Surg [Am]. 2012;37(4):651–6.CrossRef Pess GM, Pess RM, Pess RA. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers. J Hand Surg [Am]. 2012;37(4):651–6.CrossRef
40.
go back to reference Rahr L, Sondergaard P, Bisgaard T, et al. Percutaneous needle fasciotomy for primary Dupuytren's contracture. J Hand Surg Eu. 2011;36(7):548–52.CrossRef Rahr L, Sondergaard P, Bisgaard T, et al. Percutaneous needle fasciotomy for primary Dupuytren's contracture. J Hand Surg Eu. 2011;36(7):548–52.CrossRef
41.
go back to reference Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg [Am]. 2000;25(2):291–6.CrossRef Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg [Am]. 2000;25(2):291–6.CrossRef
42.
go back to reference Shin EK, Jones NF. Minimally invasive technique for release of Dupuytren's contracture: segmental fasciectomy through multiple transverse incisions. HAND. 2011;6(3):256–9.PubMedCrossRef Shin EK, Jones NF. Minimally invasive technique for release of Dupuytren's contracture: segmental fasciectomy through multiple transverse incisions. HAND. 2011;6(3):256–9.PubMedCrossRef
43.
go back to reference Skoff HD. The surgical treatment of Dupuytren's contracture: a synthesis of techniques. Plast Reconstr Surg. 2004;113(2):540–4.PubMedCrossRef Skoff HD. The surgical treatment of Dupuytren's contracture: a synthesis of techniques. Plast Reconstr Surg. 2004;113(2):540–4.PubMedCrossRef
44.
go back to reference Ullah AS, Dias JJ, Bhowal B. Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial. J Bone Joint Surg Br. 2009;91(3):374–8.PubMedCrossRef Ullah AS, Dias JJ, Bhowal B. Does a 'firebreak' full-thickness skin graft prevent recurrence after surgery for Dupuytren's contracture?: a prospective, randomised trial. J Bone Joint Surg Br. 2009;91(3):374–8.PubMedCrossRef
45.
go back to reference van Rijssen AL, Gerbrandy FS, ter Linden H, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg [Am]. 2006;31(5):717–25.CrossRef van Rijssen AL, Gerbrandy FS, ter Linden H, et al. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg [Am]. 2006;31(5):717–25.CrossRef
46.
go back to reference van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129(2):469–77.PubMedCrossRef van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129(2):469–77.PubMedCrossRef
47.
go back to reference van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in Dupuytren's disease. J Hand Surg (Br). 2006;31:498–501.CrossRef van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in Dupuytren's disease. J Hand Surg (Br). 2006;31:498–501.CrossRef
48.
go back to reference van Rijssen AL, Werker PMN. Percutaneous needle fasciotomy for recurrent Dupuytren Disease. J Hand Surg [Am]. 2012;37(9):1820–3.CrossRef van Rijssen AL, Werker PMN. Percutaneous needle fasciotomy for recurrent Dupuytren Disease. J Hand Surg [Am]. 2012;37(9):1820–3.CrossRef
49.
go back to reference Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg [Am]. 2010;35(4):534–9.CrossRef Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up. J Hand Surg [Am]. 2010;35(4):534–9.CrossRef
50.
go back to reference Weinzweig N, Culver JE, Fleegler EJ. Severe contractures of the proximal interphalangeal joint in Dupuytren's disease: combined fasciectomy with capsuloligamentous release versus fasciectomy alone. Plast Reconstr Surg. 1996;97(3):560–6.PubMedCrossRef Weinzweig N, Culver JE, Fleegler EJ. Severe contractures of the proximal interphalangeal joint in Dupuytren's disease: combined fasciectomy with capsuloligamentous release versus fasciectomy alone. Plast Reconstr Surg. 1996;97(3):560–6.PubMedCrossRef
51.
go back to reference Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg (Br). 1999;24(4):456–9.CrossRef Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren's contracture in men and women. J Hand Surg (Br). 1999;24(4):456–9.CrossRef
52.
go back to reference Wilbrand S, Flodmark C, Ekbom A, et al. Activation markers of connective tissue in Dupuytren's contracture: relation to postoperative outcome. Scand J Plast Reconstr Surg Hand Surg. 2003;37(5):283–92.PubMedCrossRef Wilbrand S, Flodmark C, Ekbom A, et al. Activation markers of connective tissue in Dupuytren's contracture: relation to postoperative outcome. Scand J Plast Reconstr Surg Hand Surg. 2003;37(5):283–92.PubMedCrossRef
53.
go back to reference Witthaut J, Jones G, Skrepnik N, et al. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg [Am]. 2013;38(1):2–11.CrossRef Witthaut J, Jones G, Skrepnik N, et al. Efficacy and safety of collagenase clostridium histolyticum injection for Dupuytren contracture: short-term results from 2 open-label studies. J Hand Surg [Am]. 2013;38(1):2–11.CrossRef
Metadata
Title
Dupuytren's disease: current state of the art
Author
Mark Henry
Publication date
01-03-2014
Publisher
Springer US
Published in
HAND / Issue 1/2014
Print ISSN: 1558-9447
Electronic ISSN: 1558-9455
DOI
https://doi.org/10.1007/s11552-013-9563-0

Other articles of this Issue 1/2014

HAND 1/2014 Go to the issue